Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Foghorn Therapeutics (FHTX) Prices 12.74M Share and Warrant Offering at $5.51/sh
-
Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants
-
Foghorn Therapeutics to Participate in Cowen’s 44th Annual Health Care Conference
-
Foghorn Therapeutics to Participate at Cowen’s 43rd Annual Health Care Conference
-
Foghorn Therapeutics to Participate at Cowen’s 43rd Annual Health Care Conference
-
Foghorn Therapeutics Announces Upcoming Investor Conference Participation
-
Foghorn Therapeutics Announces Upcoming Investor Conference Participation
-
Foghorn Therapeutics to Participate at the Cowen’s 42nd Annual Health Care Conference
-
Foghorn Therapeutics to Participate at the Cowen’s 42nd Annual Health Care Conference
-
Foghorn’s (FHTX) Lilly/Loxo Deal is All-Around Positive, Validates Robust Drug Discovery Engine - Analyst
-
Foghorn Therapeutics to Participate in the 41st Cowen Annual Healthcare Conference
-
Foghorn Therapeutics to Participate in the 41st Cowen Annual Healthcare Conference
-
UPDATE: Cowen Starts Foghorn Therapeutics (FHTX) at Outperform
-
Foghorn Therapeutics (FHTX) IPO Opens 19% Higher
-
Foghorn Therapeutics (FHTX) Prices 7.5M Share IPO at $16/Sh
-
Foghorn Therapeutics Announces Pricing of Initial Public Offering
-
Foghorn Therapeutics Announces Pricing of Initial Public Offering

